---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-134322"
form_type: "8-K"
ticker: "RNTX"
cik: "0001420565"
company_name: "Rein Therapeutics, Inc."
filed_at: "2022-04-29T23:59:59+00:00"
generated_at: "2026-06-26T02:32:44.509063+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CFO Richard J. Wanstall resigns effective May 6, 2022 for other opportunity

## Summary
- Richard J. Wanstall, CFO and principal accounting officer, resigns effective May 6, 2022 to pursue another career opportunity.
- Resignation not due to any disagreement with the company on operations, policies, or practices.
- Aileron has initiated a search for a new CFO.

## SEC filing metadata
- accession: 0001193125-22-134322
- form_type: 8-K
- ticker: RNTX
- cik: 0001420565
- company_name: Rein Therapeutics, Inc.
- filed_at: 2022-04-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420565/000119312522134322/0001193125-22-134322-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420565/000119312522134322/d266198d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-134322
- JSON: https://secwatch.observer/filing/0001193125-22-134322.json
- Plain text: https://secwatch.observer/filing/0001193125-22-134322.txt

## Key facts
- Executive change
  Richard J. Wanstall resigned as Chief Financial Officer at Rein Therapeutics, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On April 25, 2022, Richard J. Wanstall, Chief Financial Officer, principal financial officer and principal accounting officer of Aileron Therapeutics, Inc., a Delaware corporation (the “Company”), notified the Company of his resignation, effective May 6, 2022, to pursue another career opportunity.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1420565/000119312522134322/0001193125-22-134322-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.